PRTH
NASDAQ · Financial Services
Priority Technology Holdings
$7.78
+0.00 (+0.00%)
PRTH News5 articles
Musk's Memphis Presence Signals AI Buildout Priority as SpaceX Investment Surges
SpaceX shares fell 1.77% Friday, but the real signal is CEO Elon Musk's presence at the Memphis AI buildout, where capex reached $15.83B in Q2.
AMY Grupo IPO Aims to Raise VND 787 Billion, Debt Repayment Takes Priority
AMY Grupo's IPO enters payment phase, raising VND 787 billion. Most funds go to debt reduction, not expansion, as shares await October listing.
Agios Pharmaceuticals Jumps on FDA Priority Review for Sickle Cell Drug
Agios Pharmaceuticals shares jumped 14.9% after the FDA accepted its mitapivat application for sickle cell disease with Priority Review, setting a Nov. 1 PDUFA date.
Replimune Surges 85% on FDA Priority Review for Melanoma Drug
Replimune shares soared 85% after the FDA agreed to a priority review for its melanoma drug RP1, following a previous rejection. New trial data is expected soon.
Pfizer Gains on FDA Priority Review for Padcev as Pipeline Pivots Post-COVID
Pfizer shares advanced after the FDA granted priority review for its Padcev bladder cancer therapy, setting an August decision. Investors await Q1 results to gauge progress in oncology and obesity drugs against fading COVID sales.